X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2074) 2074
index medicus (977) 977
apoptosis (896) 896
female (870) 870
male (853) 853
bcl-2 (766) 766
middle aged (730) 730
oncology (719) 719
animals (670) 670
adult (611) 611
aged (591) 591
hematology (584) 584
proto-oncogene proteins c-bcl-2 - genetics (516) 516
proto-oncogene proteins c-bcl-2 - metabolism (505) 505
translocation, genetic (491) 491
pathology (447) 447
expression (445) 445
mice (405) 405
cell biology (404) 404
follicular lymphoma (388) 388
gene rearrangement (379) 379
immunohistochemistry (376) 376
non-hodgkins-lymphoma (368) 368
cancer (354) 354
prognosis (349) 349
biochemistry & molecular biology (341) 341
polymerase chain reaction (338) 338
lymphomas (328) 328
lymphoma, follicular - genetics (322) 322
aged, 80 and over (300) 300
proteins (294) 294
proto-oncogene proteins c-bcl-2 (280) 280
gene (270) 270
proto-oncogene proteins - genetics (258) 258
genes, bcl-2 (242) 242
lymphoma, b-cell - genetics (242) 242
lymphoma (239) 239
t (239) 239
apoptosis - drug effects (229) 229
gene expression (229) 229
lymphoma, large b-cell, diffuse - genetics (221) 221
b-cell lymphoma (218) 218
immunology (216) 216
research (214) 214
survival (212) 212
chromosomes, human, pair 18 (206) 206
lymphoma, follicular - pathology (206) 206
chromosomes, human, pair 14 (199) 199
immunoglobulin heavy chains - genetics (198) 198
lymphoma, b-cell - pathology (198) 198
molecular sequence data (197) 197
translocation (195) 195
in situ hybridization, fluorescence (192) 192
lymphoma, large b-cell, diffuse - pathology (189) 189
genetic aspects (185) 185
base sequence (184) 184
bcl-2 protein (184) 184
analysis (182) 182
chemotherapy (175) 175
immunophenotyping (169) 169
adolescent (167) 167
cell line, tumor (165) 165
c-myc (163) 163
p53 (163) 163
leukemia (161) 161
signal transduction (161) 161
antineoplastic combined chemotherapy protocols - therapeutic use (158) 158
rearrangement (156) 156
flow cytometry (155) 155
protein (152) 152
bcl2 (148) 148
mutation (147) 147
apoptosis - physiology (145) 145
article (145) 145
death (143) 143
gene expression regulation, neoplastic (143) 143
activation (141) 141
genetics & heredity (141) 141
genes, bcl-2 - genetics (140) 140
polymerase chain-reaction (139) 139
proto-oncogene proteins c-bcl-2 - biosynthesis (132) 132
protein expression (131) 131
hemic and lymphatic diseases (130) 130
cell-death (128) 128
mice, transgenic (128) 128
proto-oncogene proteins c-bcl-2 - analysis (128) 128
treatment outcome (128) 128
mitochondria (127) 127
chronic lymphocytic-leukemia (126) 126
tumors (126) 126
classification (125) 125
tumor cells, cultured (124) 124
proto-oncogene proteins c-myc - genetics (123) 123
rearrangements (123) 123
dna-binding proteins - genetics (121) 121
bcl-2 gene (120) 120
cell death (120) 120
proto-oncogene proteins c-bcl-6 (120) 120
cells (118) 118
bcl‐2 (117) 117
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2650) 2650
Chinese (24) 24
Japanese (12) 12
French (8) 8
Spanish (5) 5
German (4) 4
Russian (3) 3
Czech (2) 2
Hungarian (2) 2
Italian (1) 1
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 559 - 564
BACKGROUND Double‐hit lymphomas (DHLs) are collectively defined as B‐cell non‐Hodgkin lymphomas harboring rearrangements of MYC as well as B‐cell lymphoma 2... 
BCL6 (B‐cell lymphoma 6) | non‐Hodgkin lymphoma | gene rearrangement | BCL2 (B‐cell lymphoma 2) | MYC | BCL6 (B-cell lymphoma 6) | non-Hodgkin lymphoma | BCL2 (B-cell lymphoma 2) | RITUXIMAB PLUS CYCLOPHOSPHAMIDE | TRANSLOCATIONS | IN-VIVO EFFICACY | DOXORUBICIN | B-CELL LYMPHOMA | PREDNISONE | BCL6 | ONCOLOGY | VINCRISTINE | EXPRESSION | Doxorubicin - therapeutic use | Prognosis | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Bone Marrow Neoplasms - genetics | Lymphoma, B-Cell - genetics | Cyclophosphamide - therapeutic use | Lymphoma, Non-Hodgkin - pathology | Burkitt Lymphoma - pathology | Burkitt Lymphoma - genetics | Female | Burkitt Lymphoma - drug therapy | Databases, Factual | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Ifosfamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Central Nervous System Neoplasms - genetics | Etoposide - therapeutic use | Survival Rate | Germinal Center - pathology | Lymphoma, Non-Hodgkin - genetics | DNA-Binding Proteins - genetics | Genes, bcl-2 - genetics | Rituximab - administration & dosage | Central Nervous System Neoplasms - pathology | Dexamethasone - therapeutic use | Bone Marrow Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Genes, myc - genetics | Lymphoma, B-Cell - pathology | Vincristine - therapeutic use | Bone Marrow Neoplasms - drug therapy | Central Nervous System Neoplasms - drug therapy | Lymphoma, Large B-Cell, Diffuse - genetics | Prednisone - therapeutic use | Cohort Studies | Proto-Oncogene Proteins c-bcl-6 | Care and treatment | Chemotherapy | Usage | Non-Hodgkin's lymphomas | Diagnosis | Research | Oncogenes | Cancer
Journal Article
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 02/2016, Volume 40, Issue 2, pp. 253 - 261
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2017, Volume 177, Issue 4, pp. 588 - 596
Journal Article
Journal Article
Journal Article
Journal Article
Cytometry Part B: Clinical Cytometry, ISSN 1552-4949, 07/2017, Volume 92, Issue 4, pp. 310 - 314
Background B‐lymphoblastic leukemias (B‐LBL) with combined IGH/BCL2 and MYC rearrangement are rare and their clinical, cytogenetic and immunophenotypic... 
B‐lymphoblastic leukemia/lymphoma | MYC rearrangement | IGH/BCL2 translocation | immunophenotype | Immunophenotype | B-lymphoblastic leukemia/lymphoma | GENE | BCL2 translocation | lymphoma | MINIMAL DISSEMINATED DISEASE | IGH | MEDICAL LABORATORY TECHNOLOGY | PATHOLOGY | CELL LEUKEMIA | B-lymphoblastic leukemia | Antigens, CD - immunology | Translocation, Genetic | Flow Cytometry - methods | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Prognosis | Proto-Oncogene Proteins c-bcl-2 - immunology | Humans | Middle Aged | Antigens, CD - genetics | Oncogene Proteins, Fusion - immunology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Karyotyping | Adult | Female | Proto-Oncogene Proteins c-myc - immunology | Immunophenotyping | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Oncogene Proteins, Fusion - genetics | Adolescent | Survival Analysis | Immunoglobulin Heavy Chains - metabolism | Proto-Oncogene Proteins c-myc - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Immunoglobulin Heavy Chains - genetics | Analysis | Leukemia | Lymphomas | CD34 antigen | Immunohistochemistry | Translocation | Flow cytometry | Immunoglobulins | CD19 antigen | Color | Fluorescence | Data processing | Myc protein | Lymphatic leukemia | Lymphoma | DNA nucleotidylexotransferase | Literature reviews | Cytometry | Lymphocytes B | Chromosome 9 | Medical prognosis | Heavy chains | Fluorescence in situ hybridization | CD20 antigen | B-cell lymphoma
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 03/2010, Volume 34, Issue 3, pp. 327 - 340
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements, also known as "double-hit'' lymphomas (DHL), are rare neoplasms characterized by highly... 
BCL2 | Cytogenetics | High-grade B-cell lymphoma | MYC | Burkitt lymphoma | Diffuse large B-cell lymphoma | high-grade B-cell lymphoma | SURGERY | MALIGNANT-LYMPHOMAS | TRANSLOCATIONS | T(14/18) | C-MYC | FOLLICULAR LYMPHOMA | diffuse large B-cell lymphoma | PATHOLOGY | cytogenetics | POLYMERASE-CHAIN-REACTION | POOR-PROGNOSIS | ACUTE LYMPHOBLASTIC-LEUKEMIA | NON-HODGKINS-LYMPHOMA | OF-THE-LITERATURE | Predictive Value of Tests | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Male | Lymphoma, B-Cell - genetics | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Genes, Immunoglobulin Heavy Chain | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Time Factors | Karyotyping | Polymerase Chain Reaction | Aged, 80 and over | Burkitt Lymphoma - genetics | Adult | Female | Retrospective Studies | Child | Burkitt Lymphoma - therapy | Lymphoma, B-Cell - mortality | World Health Organization | Burkitt Lymphoma - classification | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols | Terminology as Topic | Immunophenotyping | In Situ Hybridization, Fluorescence | Treatment Outcome | Lymphoma, B-Cell - classification | Lymphoma, Large B-Cell, Diffuse - mortality | Gene Rearrangement, B-Lymphocyte, Heavy Chain | Lymphoma, Large B-Cell, Diffuse - classification | Adolescent | Lymphoma, B-Cell - pathology | Aged | Proto-Oncogene Proteins c-myc - genetics | Neoplasm Staging | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics
Journal Article
Journal Article